Mednow Inc. to Present at LD Micro Invitational XIII
May 29 2023 - 12:00PM
Business Wire
Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) – Mednow announced today
that it will be presenting at the 13th Annual LD Micro Invitational
at the Luxe Sunset Boulevard Hotel, California on June 6th-8th,
2023. The event is expected to feature 150+ companies, presenting
in half-hour increments, as well as private 1:1 meetings.
Mednow is scheduled to present on Wednesday, June 7th at 1:30pm
PDT. Ali Reyhany, CEO will be leading the presentation.
We invite interested parties to register to watch the
presentation virtually here: https://ldinv13.sequireevents.com/
About Mednow Mednow (TSXV: MNOW) (OTCQX:MDNWF) is a
healthcare technology company offering virtual access with a
high-standard of care. Designed with accessibility and quality of
care in mind, Mednow provides virtual pharmacy and telemedicine
services as well as doctor home visits through an interdisciplinary
approach to healthcare that is focused on the patient experience.
Mednow’s services include free at-home delivery of medications,
doctor consultations, a user-friendly interface for easy upload,
transfer, and refill of prescriptions, access to healthcare
professionals through an intuitive chat experience and the
specialized PillSmart™ system that packages prescriptions in
easy-to-use daily dose packs, each labelled with the date and time
of the next dose.
About LD Micro LD Micro, a wholly owned subsidiary of
Freedom US Markets, was founded in 2006 with the sole purpose of
being an independent resource in the micro-cap space. Whether it is
the Index, comprehensive data, or hosting the most significant
events annually, LD's sole mission is to serve as an invaluable
asset for all those interested in finding the next generation of
great companies. For more information on LD Micro, visit
www.ldmicro.com.
To present or register, please get in touch with
Dean@ldmicro.com
To learn more about Freedom US Markets, visit
www.freedomusmkts.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements:
This release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws. All statements in this news
release, other than statements of historical facts, including
statements regarding the terms of the Offering, the anticipated use
of proceeds of the Offering, and Mednow expecting to maintain its
standard of pharmacy care, while reducing operational costs, are
forward-looking statements and contain forward-looking information.
Generally, forward-looking statements and information can be
identified by the use of forward-looking terminology such as
“intends” or “anticipates”, or variations of such words and phrases
or statements that certain actions, events or results “may”,
“could”, “should”, “would” or “occur”. Forward-looking statements
are based on certain material assumptions and analysis made by the
Company and the opinions and estimates of management as of the date
of this press release including that the Offering will close and
will do so on the anticipated terms; that the Company will use the
net proceeds in the manner contemplated; and that Mednow will
maintain its standard of pharmacy care, while reducing operational
costs. These forward-looking statements are subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
the Company to be materially different from those expressed or
implied by such forward-looking statements or forward-looking
information. Important factors that may cause actual results to
vary, include, without limitation, that the Offering will not close
or will not close on the anticipated terms or timeline; that the
Company will not be able to utilize the proceeds in the manner
contemplated; and that Mednow will not maintain its standard of
pharmacy care, while also not reducing operational costs. Although
management of the Company has attempted to identify important
factors that could cause actual results to differ materially from
those contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230529005116/en/
Investor: Lorraine Cardenas 1-855-686-6300
ir@mednow.ca
Mednow (TSXV:MNOW)
Historical Stock Chart
From Dec 2024 to Jan 2025
Mednow (TSXV:MNOW)
Historical Stock Chart
From Jan 2024 to Jan 2025